nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—Biliary colic—Riluzole—amyotrophic lateral sclerosis	0.0287	0.0353	CcSEcCtD
Morphine—UGT1A8—tongue—amyotrophic lateral sclerosis	0.0255	0.227	CbGeAlD
Morphine—Faecalith—Riluzole—amyotrophic lateral sclerosis	0.0245	0.0301	CcSEcCtD
Morphine—Faecaloma—Riluzole—amyotrophic lateral sclerosis	0.0245	0.0301	CcSEcCtD
Morphine—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0231	CcSEcCtD
Morphine—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0231	CcSEcCtD
Morphine—Yawning—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0214	CcSEcCtD
Morphine—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.0171	0.021	CcSEcCtD
Morphine—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0173	CcSEcCtD
Morphine—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0164	CcSEcCtD
Morphine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0143	CcSEcCtD
Morphine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.011	0.0136	CcSEcCtD
Morphine—OPRL1—brainstem—amyotrophic lateral sclerosis	0.0109	0.0972	CbGeAlD
Morphine—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0131	CcSEcCtD
Morphine—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0126	CcSEcCtD
Morphine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0099	0.0122	CcSEcCtD
Morphine—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0099	0.0122	CcSEcCtD
Morphine—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.0099	0.0122	CcSEcCtD
Morphine—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00981	0.0121	CcSEcCtD
Morphine—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00972	0.012	CcSEcCtD
Morphine—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00938	0.0115	CcSEcCtD
Morphine—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0093	0.0114	CcSEcCtD
Morphine—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0093	0.0114	CcSEcCtD
Morphine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00907	0.0112	CcSEcCtD
Morphine—OPRM1—nerve—amyotrophic lateral sclerosis	0.00893	0.0795	CbGeAlD
Morphine—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00826	0.0102	CcSEcCtD
Morphine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00815	0.01	CcSEcCtD
Morphine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00797	0.0098	CcSEcCtD
Morphine—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00792	0.00974	CcSEcCtD
Morphine—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00765	0.00941	CcSEcCtD
Morphine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00741	0.00911	CcSEcCtD
Morphine—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00741	0.00911	CcSEcCtD
Morphine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00718	0.00883	CcSEcCtD
Morphine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00713	0.00877	CcSEcCtD
Morphine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00713	0.00877	CcSEcCtD
Morphine—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00862	CcSEcCtD
Morphine—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00862	CcSEcCtD
Morphine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00862	CcSEcCtD
Morphine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00692	0.00851	CcSEcCtD
Morphine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00692	0.00851	CcSEcCtD
Morphine—OPRL1—spinal cord—amyotrophic lateral sclerosis	0.00678	0.0604	CbGeAlD
Morphine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00676	0.00832	CcSEcCtD
Morphine—Coma—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00787	CcSEcCtD
Morphine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00624	0.00767	CcSEcCtD
Morphine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00614	0.00755	CcSEcCtD
Morphine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00748	CcSEcCtD
Morphine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00748	CcSEcCtD
Morphine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00602	0.0074	CcSEcCtD
Morphine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0059	0.00726	CcSEcCtD
Morphine—OPRL1—nervous system—amyotrophic lateral sclerosis	0.00571	0.0509	CbGeAlD
Morphine—Injury—Riluzole—amyotrophic lateral sclerosis	0.00553	0.0068	CcSEcCtD
Morphine—OPRL1—central nervous system—amyotrophic lateral sclerosis	0.0055	0.049	CbGeAlD
Morphine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00674	CcSEcCtD
Morphine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00666	CcSEcCtD
Morphine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00537	0.0066	CcSEcCtD
Morphine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00657	CcSEcCtD
Morphine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00525	0.00646	CcSEcCtD
Morphine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00511	0.00628	CcSEcCtD
Morphine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00625	CcSEcCtD
Morphine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00625	CcSEcCtD
Morphine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00505	0.0062	CcSEcCtD
Morphine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00616	CcSEcCtD
Morphine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00497	0.00611	CcSEcCtD
Morphine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00595	CcSEcCtD
Morphine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00595	CcSEcCtD
Morphine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00482	0.00592	CcSEcCtD
Morphine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00478	0.00588	CcSEcCtD
Morphine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00582	CcSEcCtD
Morphine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0047	0.00577	CcSEcCtD
Morphine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00571	CcSEcCtD
Morphine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00569	CcSEcCtD
Morphine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0046	0.00565	CcSEcCtD
Morphine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00442	0.00544	CcSEcCtD
Morphine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0054	CcSEcCtD
Morphine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0054	CcSEcCtD
Morphine—OPRL1—brain—amyotrophic lateral sclerosis	0.00437	0.0389	CbGeAlD
Morphine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00411	0.00505	CcSEcCtD
Morphine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00405	0.00498	CcSEcCtD
Morphine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00489	CcSEcCtD
Morphine—OPRM1—brainstem—amyotrophic lateral sclerosis	0.00383	0.0341	CbGeAlD
Morphine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0047	CcSEcCtD
Morphine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00468	CcSEcCtD
Morphine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00462	CcSEcCtD
Morphine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00456	CcSEcCtD
Morphine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0044	CcSEcCtD
Morphine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00434	CcSEcCtD
Morphine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00433	CcSEcCtD
Morphine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0043	CcSEcCtD
Morphine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0043	CcSEcCtD
Morphine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00427	CcSEcCtD
Morphine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00426	CcSEcCtD
Morphine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00425	CcSEcCtD
Morphine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00424	CcSEcCtD
Morphine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00404	CcSEcCtD
Morphine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00393	CcSEcCtD
Morphine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00317	0.0039	CcSEcCtD
Morphine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00388	CcSEcCtD
Morphine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00379	CcSEcCtD
Morphine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00377	CcSEcCtD
Morphine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00371	CcSEcCtD
Morphine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0037	CcSEcCtD
Morphine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.003	0.00369	CcSEcCtD
Morphine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00366	CcSEcCtD
Morphine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00364	CcSEcCtD
Morphine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00362	CcSEcCtD
Morphine—OPRD1—nervous system—amyotrophic lateral sclerosis	0.00294	0.0262	CbGeAlD
Morphine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00353	CcSEcCtD
Morphine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00349	CcSEcCtD
Morphine—OPRD1—central nervous system—amyotrophic lateral sclerosis	0.00283	0.0253	CbGeAlD
Morphine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00348	CcSEcCtD
Morphine—OPRK1—nervous system—amyotrophic lateral sclerosis	0.00282	0.0251	CbGeAlD
Morphine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00346	CcSEcCtD
Morphine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0034	CcSEcCtD
Morphine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00338	CcSEcCtD
Morphine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00338	CcSEcCtD
Morphine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00337	CcSEcCtD
Morphine—OPRK1—central nervous system—amyotrophic lateral sclerosis	0.00272	0.0242	CbGeAlD
Morphine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00333	CcSEcCtD
Morphine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00331	CcSEcCtD
Morphine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00268	0.0239	CbGeAlD
Morphine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00329	CcSEcCtD
Morphine—OPRK1—cerebellum—amyotrophic lateral sclerosis	0.00266	0.0237	CbGeAlD
Morphine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00326	CcSEcCtD
Morphine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00325	CcSEcCtD
Morphine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00321	CcSEcCtD
Morphine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00321	CcSEcCtD
Morphine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0032	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00318	CcSEcCtD
Morphine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00317	CcSEcCtD
Morphine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00314	CcSEcCtD
Morphine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00252	0.0031	CcSEcCtD
Morphine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00307	CcSEcCtD
Morphine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00307	CcSEcCtD
Morphine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00305	CcSEcCtD
Morphine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00302	CcSEcCtD
Morphine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00301	CcSEcCtD
Morphine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00301	CcSEcCtD
Morphine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00244	0.003	CcSEcCtD
Morphine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00299	CcSEcCtD
Morphine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00297	CcSEcCtD
Morphine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00293	CcSEcCtD
Morphine—OPRM1—spinal cord—amyotrophic lateral sclerosis	0.00238	0.0212	CbGeAlD
Morphine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00287	CcSEcCtD
Morphine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0028	CcSEcCtD
Morphine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00278	CcSEcCtD
Morphine—OPRD1—brain—amyotrophic lateral sclerosis	0.00225	0.02	CbGeAlD
Morphine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00276	CcSEcCtD
Morphine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00274	CcSEcCtD
Morphine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00273	CcSEcCtD
Morphine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00271	CcSEcCtD
Morphine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00267	CcSEcCtD
Morphine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00265	CcSEcCtD
Morphine—OPRK1—brain—amyotrophic lateral sclerosis	0.00216	0.0192	CbGeAlD
Morphine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00265	CcSEcCtD
Morphine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00263	CcSEcCtD
Morphine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00263	CcSEcCtD
Morphine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00253	CcSEcCtD
Morphine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00251	CcSEcCtD
Morphine—OPRM1—nervous system—amyotrophic lateral sclerosis	0.00201	0.0179	CbGeAlD
Morphine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00244	CcSEcCtD
Morphine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00243	CcSEcCtD
Morphine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00243	CcSEcCtD
Morphine—OPRM1—central nervous system—amyotrophic lateral sclerosis	0.00193	0.0172	CbGeAlD
Morphine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00226	CcSEcCtD
Morphine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00221	CcSEcCtD
Morphine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00217	CcSEcCtD
Morphine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0021	CcSEcCtD
Morphine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00203	CcSEcCtD
Morphine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00195	CcSEcCtD
Morphine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00194	CcSEcCtD
Morphine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00194	CcSEcCtD
Morphine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00193	CcSEcCtD
Morphine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00154	0.0137	CbGeAlD
Morphine—OPRM1—brain—amyotrophic lateral sclerosis	0.00153	0.0137	CbGeAlD
Morphine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00183	CcSEcCtD
Morphine—ABCB1—embryo—amyotrophic lateral sclerosis	0.00121	0.0107	CbGeAlD
Morphine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000923	0.00822	CbGeAlD
Morphine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000818	0.00729	CbGeAlD
Morphine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000805	0.00717	CbGeAlD
Morphine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000787	0.00702	CbGeAlD
Morphine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000775	0.0069	CbGeAlD
Morphine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000771	0.00687	CbGeAlD
Morphine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000757	0.00675	CbGeAlD
Morphine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000687	0.00612	CbGeAlD
Morphine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000615	0.00548	CbGeAlD
Morphine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000579	0.00516	CbGeAlD
Morphine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000557	0.00497	CbGeAlD
Morphine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000545	0.00485	CbGeAlD
Morphine—ABCB1—brain—amyotrophic lateral sclerosis	0.000443	0.00394	CbGeAlD
Morphine—OPRK1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000226	0.00304	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000226	0.00303	CbGpPWpGaD
Morphine—UGT1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000223	0.00299	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000221	0.00297	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000221	0.00296	CbGpPWpGaD
Morphine—UGT1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00022	0.00295	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000219	0.00294	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000218	0.00292	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000216	0.00289	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000215	0.00289	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00021	0.00282	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00021	0.00282	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00021	0.00282	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000209	0.0028	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000202	0.00271	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000198	0.00265	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000194	0.0026	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000192	0.00258	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000192	0.00257	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000192	0.00257	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000191	0.00257	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000188	0.00252	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000186	0.0025	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000185	0.00249	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000185	0.00248	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000183	0.00246	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000179	0.0024	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000179	0.0024	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000175	0.00235	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000172	0.0023	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000171	0.00229	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000171	0.00229	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000168	0.00225	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000164	0.00219	CbGpPWpGaD
Morphine—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000163	0.00219	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000163	0.00219	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000162	0.00217	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000156	0.0021	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000155	0.00208	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000153	0.00206	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000152	0.00204	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000152	0.00204	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000149	0.002	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000148	0.00199	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000148	0.00198	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000146	0.00196	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000145	0.00195	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000141	0.00189	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000139	0.00186	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000138	0.00185	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000137	0.00183	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000136	0.00182	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000136	0.00182	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000133	0.00178	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00013	0.00174	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000128	0.00172	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000127	0.0017	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000126	0.00169	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000125	0.00168	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000124	0.00166	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000118	0.00159	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000118	0.00158	CbGpPWpGaD
Morphine—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000117	0.00157	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000116	0.00156	CbGpPWpGaD
Morphine—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000116	0.00155	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000115	0.00155	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000113	0.00151	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000113	0.00151	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000111	0.00148	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00011	0.00147	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000108	0.00145	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000108	0.00145	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000107	0.00144	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000106	0.00143	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000103	0.00139	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000103	0.00138	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000103	0.00138	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000103	0.00138	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	9.88e-05	0.00133	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	9.82e-05	0.00132	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.71e-05	0.0013	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.64e-05	0.00129	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.63e-05	0.00129	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.51e-05	0.00128	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.47e-05	0.00127	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.47e-05	0.00127	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.36e-05	0.00126	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.21e-05	0.00123	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	9.17e-05	0.00123	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.06e-05	0.00121	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	9.06e-05	0.00121	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	9.06e-05	0.00121	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	9e-05	0.00121	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	9e-05	0.00121	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	8.98e-05	0.0012	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.92e-05	0.0012	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—APOE—amyotrophic lateral sclerosis	8.91e-05	0.0012	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	8.73e-05	0.00117	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	8.64e-05	0.00116	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	8.64e-05	0.00116	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	8.52e-05	0.00114	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.39e-05	0.00113	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	8.35e-05	0.00112	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	8.23e-05	0.0011	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.17e-05	0.0011	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.07e-05	0.00108	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.01e-05	0.00107	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.92e-05	0.00106	CbGpPWpGaD
Morphine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.84e-05	0.00105	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.84e-05	0.00105	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.83e-05	0.00105	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.82e-05	0.00105	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—APOE—amyotrophic lateral sclerosis	7.79e-05	0.00104	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—APOE—amyotrophic lateral sclerosis	7.79e-05	0.00104	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	7.78e-05	0.00104	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	7.66e-05	0.00103	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.65e-05	0.00103	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.45e-05	0.001	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	7.39e-05	0.000991	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	7.39e-05	0.000991	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.2e-05	0.000965	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	7.19e-05	0.000965	CbGpPWpGaD
Morphine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	7.17e-05	0.000962	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.1e-05	0.000952	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.95e-05	0.000932	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.95e-05	0.000932	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.94e-05	0.000931	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.86e-05	0.000921	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	6.82e-05	0.000915	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	6.76e-05	0.000906	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.67e-05	0.000894	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.61e-05	0.000886	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.55e-05	0.000878	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	6.51e-05	0.000872	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.37e-05	0.000854	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.3e-05	0.000845	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.28e-05	0.000842	CbGpPWpGaD
Morphine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.27e-05	0.00084	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.22e-05	0.000834	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.19e-05	0.000831	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.16e-05	0.000826	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.11e-05	0.000819	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.91e-05	0.000792	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	5.88e-05	0.000788	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.87e-05	0.000787	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.8e-05	0.000778	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.78e-05	0.000776	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.74e-05	0.00077	CbGpPWpGaD
Morphine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	5.67e-05	0.00076	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.59e-05	0.000749	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.52e-05	0.00074	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.38e-05	0.000721	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	5.34e-05	0.000716	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.34e-05	0.000716	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.34e-05	0.000716	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.07e-05	0.00068	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.07e-05	0.00068	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.04e-05	0.000677	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	4.93e-05	0.000661	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	4.87e-05	0.000654	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.85e-05	0.000651	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.83e-05	0.000648	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.83e-05	0.000648	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.8e-05	0.000644	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.74e-05	0.000636	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.72e-05	0.000633	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.72e-05	0.000633	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.69e-05	0.000629	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	4.55e-05	0.00061	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.52e-05	0.000607	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.48e-05	0.000601	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.42e-05	0.000593	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	4.42e-05	0.000592	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.31e-05	0.000578	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.3e-05	0.000576	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.29e-05	0.000575	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.21e-05	0.000565	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—APOE—amyotrophic lateral sclerosis	4.17e-05	0.00056	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.14e-05	0.000556	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.11e-05	0.000552	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.11e-05	0.000551	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.05e-05	0.000543	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.02e-05	0.000539	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.99e-05	0.000535	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	3.96e-05	0.000532	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.87e-05	0.000519	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.86e-05	0.000518	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.84e-05	0.000515	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.81e-05	0.000511	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.74e-05	0.000501	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	3.74e-05	0.000501	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	3.74e-05	0.000501	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.61e-05	0.000484	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.56e-05	0.000478	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	3.55e-05	0.000476	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.5e-05	0.00047	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.49e-05	0.000468	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.42e-05	0.000458	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.41e-05	0.000457	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.39e-05	0.000455	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.26e-05	0.000437	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.18e-05	0.000427	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.07e-05	0.000411	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.05e-05	0.000409	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.04e-05	0.000408	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3e-05	0.000402	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.9e-05	0.000389	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	2.88e-05	0.000387	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.87e-05	0.000384	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.86e-05	0.000383	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.79e-05	0.000374	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.65e-05	0.000355	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.63e-05	0.000353	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.53e-05	0.00034	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.44e-05	0.000328	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.43e-05	0.000326	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.36e-05	0.000316	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.34e-05	0.000313	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.31e-05	0.000309	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.02e-05	0.000271	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.01e-05	0.000269	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.01e-05	0.000269	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.98e-05	0.000265	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.95e-05	0.000261	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.91e-05	0.000256	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.85e-05	0.000247	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.77e-05	0.000238	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.75e-05	0.000235	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.72e-05	0.00023	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.68e-05	0.000225	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.65e-05	0.000221	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.61e-05	0.000216	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.52e-05	0.000204	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.51e-05	0.000203	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.51e-05	0.000202	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.5e-05	0.000201	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.42e-05	0.00019	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.32e-05	0.000177	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.3e-05	0.000174	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.27e-05	0.000171	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.25e-05	0.000167	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.14e-05	0.000153	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.08e-05	0.000145	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.04e-05	0.00014	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.9e-06	0.000133	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.61e-06	0.000129	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.06e-06	0.000122	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.54e-06	0.000115	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	8.15e-06	0.000109	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.58e-06	7.49e-05	CbGpPWpGaD
